Quantum BioPharma Ltd
QNTM25.997USD
+2.297+9.69%
交易中 （美东）报价延迟15分钟
70.48M总市值
亏损市盈率 TTM
关于 Quantum BioPharma Ltd 公司
Quantum BioPharma Ltd. 是一家总部位于加拿大的生物制药公司。该公司致力于建立资产和生物技术解决方案组合，用于治疗具有挑战性的神经退行性疾病和代谢性疾病以及酒精滥用障碍，其候选药物处于不同的开发阶段。通过其全资子公司 Lucid Psycheceuticals Inc. (Lucid)，该公司专注于其先导化合物 Lucid-MS 的研发，这是一种获得专利的新化学实体，用于预防和逆转髓鞘降解，髓鞘降解是多发性硬化症的潜在机制。其 unbuzzd 饮料是一种专有的维生素和矿物质配方，有助于肝脏和大脑功能，从而缓解饮酒的影响并恢复正常的生活方式。它通过其全资子公司 FSD Strategic Investments Inc. 维持着战略投资组合，该投资组合代表以住宅或商业地产为抵押的贷款。
公司简介
公司代码QNTM
公司名称Quantum BioPharma Ltd
上市日期May 29, 2018
CEODr. Lakshmi P. Kotra, Ph.D.
员工数量- -
证券类型Ordinary Share
年结日May 29
公司地址55 University Ave. , Suite 1003
城市TORONTO
上市交易所Canadian Securities Exchange - CSE Listed
国家Canada
邮编M5J 2H7
电话14168548884
网址https://www.quantumbiopharma.com/
公司代码QNTM
上市日期May 29, 2018
CEODr. Lakshmi P. Kotra, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Zeeshan Saeed
Mr. Zeeshan Saeed
Executive Co-Chairman of the Board, President, Chief Executive Officer
Executive Co-Chairman of the Board, President, Chief Executive Officer
118.11K
+6.97%
Mr. Anthony Durkacz
Mr. Anthony Durkacz
Co-Executive Chairman of the Board
Co-Executive Chairman of the Board
106.76K
+0.66%
Mr. Donal Carroll, CPA
Mr. Donal Carroll, CPA
Chief Financial Officer
Chief Financial Officer
90.41K
+9.30%
Ashwini Joshi,
Ashwini Joshi,
Director of Pharmaceutical Development
Director of Pharmaceutical Development
--
--
Mr. Adnan Bashir
Mr. Adnan Bashir
Independent Director
Independent Director
--
--
Mr. Joseph L. Romano
Mr. Joseph L. Romano
Director
Director
--
--
Mr. Lawrence (Larry) Latowsky
Mr. Lawrence (Larry) Latowsky
Independent Director
Independent Director
--
--
Mr. Kevin Cassidy
Mr. Kevin Cassidy
Vice President - Quality of Lucid
Vice President - Quality of Lucid
--
--
Dr. Andrzej Chruscinski, M.D., Ph.D.
Dr. Andrzej Chruscinski, M.D., Ph.D.
Vice President - Clinical and Scientific Affairs
Vice President - Clinical and Scientific Affairs
--
-100.00%
Dr. Lakshmi P. Kotra, Ph.D.
Dr. Lakshmi P. Kotra, Ph.D.
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD Australia
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD Australia
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Zeeshan Saeed
Mr. Zeeshan Saeed
Executive Co-Chairman of the Board, President, Chief Executive Officer
Executive Co-Chairman of the Board, President, Chief Executive Officer
118.11K
+6.97%
Mr. Anthony Durkacz
Mr. Anthony Durkacz
Co-Executive Chairman of the Board
Co-Executive Chairman of the Board
106.76K
+0.66%
Mr. Donal Carroll, CPA
Mr. Donal Carroll, CPA
Chief Financial Officer
Chief Financial Officer
90.41K
+9.30%
Ashwini Joshi,
Ashwini Joshi,
Director of Pharmaceutical Development
Director of Pharmaceutical Development
--
--
Mr. Adnan Bashir
Mr. Adnan Bashir
Independent Director
Independent Director
--
--
Mr. Joseph L. Romano
Mr. Joseph L. Romano
Director
Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月25日 周五
更新时间: 7月25日 周五
持股股东
股东类型
持股股东
持股股东
占比
Malone Wealth Ventures LLC
21.76%
Saeed (Zeeshan)
3.10%
Durkacz (Anthony)
2.80%
Carroll (Donal)
2.37%
AdvisorShares Investments, LLC
1.28%
Other
68.68%
持股股东
持股股东
占比
Malone Wealth Ventures LLC
21.76%
Saeed (Zeeshan)
3.10%
Durkacz (Anthony)
2.80%
Carroll (Donal)
2.37%
AdvisorShares Investments, LLC
1.28%
Other
68.68%
股东类型
持股股东
占比
Investment Advisor
23.49%
Individual Investor
9.23%
Corporation
0.37%
Investment Advisor/Hedge Fund
0.22%
Hedge Fund
0.08%
Other
66.61%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
50
1.05M
34.28%
+341.83K
2025Q1
50
413.46K
17.05%
-229.58K
2024Q4
44
604.87K
28.35%
+138.76K
2024Q3
45
583.17K
30.09%
+414.87K
2024Q2
43
126.91K
14.87%
-21.03K
2024Q1
47
105.72K
14.06%
-57.49K
2023Q4
49
159.35K
26.32%
+20.22K
2023Q3
52
164.58K
27.23%
+48.13K
2023Q2
52
164.21K
27.10%
+38.85K
2023Q1
56
112.96K
18.07%
-21.18K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Malone Wealth Ventures LLC
610.37K
20.82%
+610.37K
--
Jun 23, 2025
Saeed (Zeeshan)
118.11K
4.03%
+7.69K
+6.97%
Apr 03, 2025
Durkacz (Anthony)
106.06K
3.62%
+7.69K
+7.82%
Apr 03, 2025
Carroll (Donal)
90.41K
3.08%
+7.69K
+9.30%
Apr 03, 2025
AdvisorShares Investments, LLC
48.99K
1.67%
-283.32K
-85.26%
Mar 31, 2025
Kotra (Lakshmi)
29.57K
1.01%
+7.69K
+35.15%
Apr 03, 2025
J.W. Cole Advisors, Inc.
12.59K
0.43%
+12.59K
--
Mar 31, 2025
Global X Investments Canada Inc.
8.24K
0.28%
-1.31K
-13.73%
Feb 29, 2024
Saeed (Rehan)
6.79K
0.23%
-2.15K
-24.09%
Dec 31, 2024
Xorax Family Trust
6.79K
0.23%
--
--
Dec 31, 2024
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
AdvisorShares Psychedelics ETF
9.02%
AdvisorShares Psychedelics ETF
占比9.02%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
公告日期
类型
比率
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
